The store will not work correctly when cookies are disabled.
BETA-PHENYLETHYLIDENE HYDRAZINE
ID: ALA2235132
Max Phase: Preclinical
Molecular Formula: C8H10N2
Molecular Weight: 134.18
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: N/N=C/Cc1ccccc1
Standard InChI: InChI=1S/C8H10N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,7H,6,9H2/b10-7+
Standard InChI Key: RUZSWLOEFLRSGJ-JXMROGBWSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 134.18 | Molecular Weight (Monoisotopic): 134.0844 | AlogP: 1.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 38.38 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.56 | CX LogP: 1.17 | CX LogD: 1.17 |
Aromatic Rings: 1 | Heavy Atoms: 10 | QED Weighted: 0.37 | Np Likeness Score: -0.03 |
References
1. Bansal SK, Sinha BN, Khosa RL, Olson AJ. (2011) Novel GABA-AT inhibitors: QSAR and docking based virtual screening of phenyl substituted -phenyl ethylidene hydrazine analogues, 20 (9): [10.1007/s00044-010-9390-6] |